Literature DB >> 6547150

Lithocholate glucuronide is a cholestatic agent.

D G Oelberg, M V Chari, J M Little, E W Adcock, R Lester.   

Abstract

Lithocholic acid and its taurine, glycine, and sulfate derivatives are potent cholestatic agents. Lithocholate glucuronide is present in the plasma and urine of patients with cholestatic syndromes, but little is known of its metabolism, excretion, and cholestatic potential. [3 beta-3H]lithocholate 3-O-beta-D-glucuronide was synthesized, and chemical and radiochemical purity were established. The aqueous solubility of lithocholate glucuronide was determined and found to be greater than that of lithocholic acid or several of its derivatives. In the range of concentrations examined, calcium ions precipitated lithocholate glucuronide stoichiometrically. The material was administered to rats prepared with an external biliary fistula. When 17-25 micrograms quantities were administered, 89.1 +/- 4.5% (mean +/- SEM) of the radiolabel was secreted in bile within the first 20 h after administration, the major fraction being secreted in less than 20 min. Four-fifths of the radiolabeled material in bile was the administered unaltered parent compound, while a minor fraction consisted of a more polar derivative(s). We showed that increasing biliary concentrations of more polar derivatives were observed with milligram doses of [3H]lithocholate glucuronide, and with time after the administration of these loading doses. Milligram doses of [3H]lithocholate glucuronide resulted in partial or complete cholestasis. When induced cholestasis was partial, secretion in bile remained the primary excretory route (82.5-105.6% recovery in bile), while, when complete cholestasis was induced, wide tissue distribution of radiolabel was observed. Cholestasis developed rapidly during infusion of [3H]lithocholate glucuronide. Bile flow was diminished within 10-20 min of the start of an infusion of 0.05 mumol, 100 g-1 body weight, minute-1, administered concomitantly with an equimolar infusion of taurocholate. The results establish that lithocholate glucuronide exerts cholestatic effects comparable to those exerted by unconjugated lithocholic acid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547150      PMCID: PMC437060          DOI: 10.1172/JCI111356

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats.

Authors:  G Kakis; I M Yousef
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

Review 2.  Relationships between calcium and cyclic nucleotides in cell activation.

Authors:  H Rasmussen; D B Goodman
Journal:  Physiol Rev       Date:  1977-07       Impact factor: 37.312

3.  The respective roles of membrane cholesterol and of sodium potassium adenosine triphosphatase in the pathogenesis of lithocholate-induced cholestasis.

Authors:  G Kakis; M J Phillips; I M Yousef
Journal:  Lab Invest       Date:  1980-07       Impact factor: 5.662

4.  Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.

Authors:  A E Cowen; M G Korman; A F Hofmann; O W Cass; S B Coffin
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

5.  Bile acid glucuronides, III[1, 2]. Chemical synthesis and characterization of glucuronic acid coupled mono-, di- and trihydroxy bile acids.

Authors:  P Back; D V Bowen
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-02

6.  Bile salt glucuronides: identification and quantitative analysis in the urine of patients with cholestasis.

Authors:  W Fröhling; A Stiehl
Journal:  Eur J Clin Invest       Date:  1976-01-30       Impact factor: 4.686

7.  Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.

Authors:  B Almé; A Bremmelgaard; J Sjövall; P Thomassen
Journal:  J Lipid Res       Date:  1977-05       Impact factor: 5.922

8.  The formation of lithocholic acid, chenodeoxycholic acid and alpha- and beta-muricholic acids from cholesterol incubated with rat-liver mitochondria.

Authors:  K A Mitropoulos; N B Myant
Journal:  Biochem J       Date:  1967-05       Impact factor: 3.857

9.  Constituents of human meconium--I. Identification of 3-hydroxy-etianic acids.

Authors:  J St Pyrek; R Lester; E W Adcock; A T Sanghvi
Journal:  J Steroid Biochem       Date:  1983-03       Impact factor: 4.292

10.  Choleretic and cholestatic effects of infused bile salts in the rat.

Authors:  R Drew; B G Priestly
Journal:  Experientia       Date:  1979-06-15
View more
  19 in total

1.  Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat.

Authors:  F Kuipers; M Enserink; R Havinga; A B van der Steen; M J Hardonk; J Fevery; R J Vonk
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Fetal and neonatal bile acid synthesis and metabolism--clinical implications.

Authors:  W F Balistreri
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 4.  Cellular mechanisms of intrahepatic cholestasis.

Authors:  P J Meier-Abt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

Authors:  Kyunghee Yang; Cen Guo; Jeffrey L Woodhead; Robert L St Claire; Paul B Watkins; Scott Q Siler; Brett A Howell; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

6.  Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene.

Authors:  Athena Starlard-Davenport; Beverly Lyn-Cook; Anna Radominska-Pandya
Journal:  Steroids       Date:  2007-09-29       Impact factor: 2.668

7.  Cholesterol synthesis in the pathogenesis of lithocholic acid-induced cholestasis.

Authors:  I M Yousef; B Tuchweber; R Morazain; R Kugelmass; M Gauvin; C C Roy; A M Weber
Journal:  Lipids       Date:  1988-03       Impact factor: 1.880

8.  The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liver.

Authors:  Jocelyn Trottier; Diala El Husseini; Martin Perreault; Sophie Pâquet; Patrick Caron; Sylvie Bourassa; Mélanie Verreault; Ted T Inaba; Guy G Poirier; Alain Bélanger; Chantal Guillemette; Michael Trauner; Olivier Barbier
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

9.  Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.

Authors:  H Takikawa; K Minagawa; N Sano; M Yamanaka
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

10.  Effects of taurolithocholate, a Ca2(+)-mobilizing agent, on cell Ca2(+) in rat hepatocytes, human platelets and neuroblastoma NG108-15 cell line.

Authors:  J F Coquil; B Berthon; N Chomiki; L Combettes; P Jourdon; C Schteingart; S Erlinger; M Claret
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.